Thyroid hormone receptor beta agonist compounds
US10800767B2 · kind B2 · utility
8Cited by
0References
21Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2019 |
| Grant date | Oct 13, 2020 |
| Priority date | — |
| Expiry date | Aug 23, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P3/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Provided herein are compounds, preferably thyroid hormone receptor beta (THR beta) agonist compounds, compositions thereof, and methods of their preparation, and methods of agonizing THR beta and methods for treating disorders mediated by THR beta.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.